Register by Jan 13 to save on passes and connect with marketers from Uber, Bose and more
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Inside the brand and agency scramble for first-party data in the AI era
Brands are moving faster to own first-party data as AI and privacy changes alter the digital advertising landscape.
Walmart Connect takes a play out of the Amazon playbook to make agentic AI the next battleground in retail media
The next retail media war is between Walmart Connect’s Sparky and Amazon’s Rufus, driven by agentic AI and first-party data.
What does media spend look like for 2026? It could be worse — and it might be
Forecasts for 2026 media spend range from 6.6% on the lower end to over 10% but the primary beneficiaries will be commerce, social and search.